{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:39:06Z","timestamp":1785476346226,"version":"3.56.0"},"reference-count":26,"publisher":"Baskent University","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.6002\/ect.2017.0154","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T07:23:37Z","timestamp":1521012217000},"page":"42-46","source":"Crossref","is-referenced-by-count":13,"title":["Management of Plasma Cell-Rich Acute Rejection in Living-Related Kidney Transplant: Role of Proteasome Inhibitor"],"prefix":"10.6002","volume":"17","author":[{"name":"the Department of Transplant Immunology, Sindh Institute of Urology and Transplantation, Karachi, Pakistan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khawar","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Mubarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirza Naqi","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajiha","family":"Musharraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehjabeen","family":"Imam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adibul Hassan","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4021","reference":[{"issue":"6","key":"ref0","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/00007890-199909270-00011","article-title":"Plasma cell-rich acute renal allograft rejection","volume":"68","author":"Charney","year":"1999","unstructured":"1. Charney DA, Nadasdy T, Lo AW, Racusen LC. Plasma cell-rich acute renal allograft rejection. Transplantation. 1999;68(6):791-797.","journal-title":"Transplantation"},{"issue":"2","key":"ref1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1053\/hupa.2001.21574","article-title":"The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies","volume":"32","author":"Meehan","year":"2001","unstructured":"2. Meehan SM, Domer P, Josephson M, et al. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol. 2001;32(2):205-215.","journal-title":"Hum Pathol"},{"issue":"4","key":"ref2","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/ndt\/gfh027","article-title":"Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: high gamma-interferon expression and poor clinical outcome","volume":"19","author":"Desvaux","year":"2004","unstructured":"3. Desvaux D, Le Gouvello S, Pastural M, et al. Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: high gamma-interferon expression and poor clinical outcome. Nephrol Dial Transplant. 2004;19(4):933-939.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"ref3","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1097\/01.tp.0000215014.40595.ab","article-title":"Plasma cell-rich rejection processes in renal transplantation: morphology and prognostic relevance","volume":"81","author":"Gartner","year":"2006","unstructured":"4. Gartner V, Eigentler TK, Viebahn R. Plasma cell-rich rejection processes in renal transplantation: morphology and prognostic relevance. Transplantation. 2006;81(7):986-991.","journal-title":"Transplantation"},{"issue":"8","key":"ref4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1440-1797.2011.01487.x","article-title":"Plasma cell infiltrates and renal allograft outcomes in indigenous and non-indigenous people of the Northern Territory of Australia","volume":"16","author":"Rogers","year":"2011","unstructured":"5. Rogers NM, Lawton PD, Jose MD. Plasma cell infiltrates and renal allograft outcomes in indigenous and non-indigenous people of the Northern Territory of Australia. Nephrology (Carlton). 2011;16(8):777-783.","journal-title":"Nephrology (Carlton)"},{"issue":"9","key":"ref5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/ctr.12589","article-title":"Plasma cell-rich acute rejections in living-related kidney transplantation: a clinicopathological study of 50 cases","volume":"29","author":"Abbas","year":"2015","unstructured":"6. Abbas K, Mubarak M, Zafar MN, et al. Plasma cell-rich acute rejections in living-related kidney transplantation: a clinicopathological study of 50 cases. Clin Transplant. 2015;29(9):835-841.","journal-title":"Clin Transplant"},{"issue":"3","key":"ref6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4103\/0971-4065.159300","article-title":"Expanding the antibody-mediated component of plasma cell-rich acute rejection: A case series","volume":"26","author":"Uppin","year":"2016","unstructured":"7. Uppin MS, Gudithi S, Taduri G, Prayaga AK, Raju SB. Expanding the antibody-mediated component of plasma cell-rich acute rejection: A case series. Indian J Nephrol. 2016;26(3):176-181.","journal-title":"Indian J Nephrol"},{"issue":"3","key":"ref7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4103\/0971-4065.161520","article-title":"Plasma cell-rich acute rejection: A morphologic archetype of combined cellular and humoral rejection","volume":"26","author":"Mubarak","year":"2016","unstructured":"8. Mubarak M. Plasma cell-rich acute rejection: A morphologic archetype of combined cellular and humoral rejection? Indian J Nephrol. 2016;26(3):157-158.","journal-title":"Indian J Nephrol"},{"issue":"8","key":"ref8","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.transproceed.2015.09.018","article-title":"Plasma cell-rich rejection after kidney transplantation and the role of donor-specific antibodies: a case report and review of the literature","volume":"47","author":"Hasegawa","year":"2015","unstructured":"9. Hasegawa J, Honda K, Wakai S, et al. Plasma cell-rich rejection after kidney transplantation and the role of donor-specific antibodies: a case report and review of the literature. Transplant Proc. 2015;47(8):2533-2536.","journal-title":"Transplant Proc"},{"issue":"4","key":"ref9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/01.tp.0000231922.11453.ec","article-title":"Immunoglobulin therapy for plasma cell-rich rejection in the renal allograft","volume":"82","author":"Adrogue","year":"2006","unstructured":"10. Adrogue HE, Soltero L, Land GA, Ramanathan V, Truong LD, Suki WN. Immunoglobulin therapy for plasma cell-rich rejection in the renal allograft. Transplantation. 2006;82(4):567-569.","journal-title":"Transplantation"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/nep.12245","article-title":"Plasma cell-rich rejection accompanied by acute antibody-mediated rejection in a patient with ABO-incompatible kidney transplantation.","volume":"19","author":"Furuya","year":"2014","unstructured":"11. Furuya M, Yamamoto I, Kobayashi A, et al. Plasma cell-rich rejection accompanied by acute antibody-mediated rejection in a patient with ABO-incompatible kidney transplantation. Nephrology (Carlton). 2014;19 Suppl 3:31-34.","journal-title":"Nephrology (Carlton)","ISSN":"https:\/\/id.crossref.org\/issn\/1320-5358","issn-type":"print"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1399-0012.2005.00394.x","article-title":"Renal graft loss with plasma cell-rich acute rejection in cadaveric renal transplantation: a case report.","volume":"19","author":"Suzuki","year":"2005","unstructured":"12. Suzuki T, Fukuzawa J, Furuya S, et al. Renal graft loss with plasma cell-rich acute rejection in cadaveric renal transplantation: a case report. Clin Transplant. 2005;19 Suppl 14:71-75.","journal-title":"Clin Transplant","ISSN":"https:\/\/id.crossref.org\/issn\/0902-0063","issn-type":"print"},{"issue":"2","key":"ref12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","unstructured":"13. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55(2):713-723.","journal-title":"Kidney Int"},{"issue":"2","key":"ref13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","unstructured":"14. Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant. 2014;14(2):272-283.","journal-title":"Am J Transplant"},{"issue":"6","key":"ref14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection","volume":"3","author":"Racusen","year":"2003","unstructured":"15. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant. 2003;3(6):708-714.","journal-title":"Am J Transplant"},{"issue":"3","key":"ref15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4103\/0971-4065.98753","article-title":"Plasma cell-rich acute rejection of the renal allograft: A distinctive morphologic form of acute rejection","volume":"22","author":"Gupta","year":"2012","unstructured":"16. Gupta R, Sharma A, Mahanta PJ, Agarwal SK, Dinda AK. Plasma cell-rich acute rejection of the renal allograft: A distinctive morphologic form of acute rejection? Indian J Nephrol. 2012;22(3):184-188.","journal-title":"Indian J Nephrol"},{"issue":"3-4","key":"ref16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.trim.2009.11.001","article-title":"Detection of plasma cells, C4d deposits and donor-specific antibodies on sequential graft biopsies of renal transplant recipients with chronic dysfunction.","volume":"22","author":"Martin","year":"2010","unstructured":"17. Martin L, Charon-Barra C, Bocrie O, et al. Detection of plasma cells, C4d deposits and donor-specific antibodies on sequential graft biopsies of renal transplant recipients with chronic dysfunction. Transpl Immunol. 2010;22(3-4):110-114.","journal-title":"Transpl Immunol","ISSN":"https:\/\/id.crossref.org\/issn\/0966-3274","issn-type":"print"},{"issue":"11","key":"ref17","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1093\/ndt\/gfq502","article-title":"Bortezomib: a new player in pre- and post-transplant desensitization","volume":"25","author":"Lemy","year":"2010","unstructured":"18. Lemy A, Toungouz M, Abramowicz D. Bortezomib: a new player in pre- and post-transplant desensitization? Nephrol Dial Transplant. 2010;25(11):3480-3489.","journal-title":"Nephrol Dial Transplant"},{"key":"ref18","first-page":"339","article-title":"Bortezomib in kidney transplant desensitization: a case report.","author":"Raghavan","year":"2009","unstructured":"19. Raghavan R, Jeroudi A, Achkar K, et al. Bortezomib in kidney transplant desensitization: a case report. Clin Transpl. 2009:339-342.","journal-title":"Clin Transpl","ISSN":"https:\/\/id.crossref.org\/issn\/0890-9016","issn-type":"print"},{"issue":"5","key":"ref19","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1097\/TXD.0000000000000526","article-title":"A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly Sensitized Kidney Transplant Candidates.","volume":"1","author":"Ide","year":"2015","unstructured":"20. Ide K, Tanaka Y, Sasaki Y, et al. A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly Sensitized Kidney Transplant Candidates. Transplant Direct. 2015;1(5):e17.","journal-title":"Transplant Direct"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"6. Raghavan R, Jeroudi A, Achkar K, Gaber AO, Patel SJ, Abdellatif A. Bortezomib in kidney transplantation. J Transplant. 2010;2010.","DOI":"10.1155\/2010\/698594"},{"issue":"3","key":"ref21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/TP.0b013e3181c6ff8d","article-title":"Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection","volume":"89","author":"Walsh","year":"2010","unstructured":"22. Walsh RC, Everly JJ, Brailey P, et al. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection. Transplantation. 2010;89(3):277-284.","journal-title":"Transplantation"},{"issue":"1","key":"ref22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production","volume":"9","author":"Perry","year":"2009","unstructured":"23. Perry DK, Burns JM, Pollinger HS, et al. Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production. Am J Transplant. 2009;9(1):201-209.","journal-title":"Am J Transplant"},{"key":"ref23","first-page":"323","article-title":"A summary of bortezomib use in transplantation across 29 centers.","author":"Everly","year":"2009","unstructured":"24. Everly MJ. A summary of bortezomib use in transplantation across 29 centers. Clin Transpl. 2009:323-337.","journal-title":"Clin Transpl","ISSN":"https:\/\/id.crossref.org\/issn\/0890-9016","issn-type":"print"},{"issue":"1","key":"ref24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/ajt.13050","article-title":"Prospective iterative trial of proteasome inhibitor-based desensitization","volume":"15","author":"Woodle","year":"2015","unstructured":"25. Woodle ES, Shields AR, Ejaz NS, et al. Prospective iterative trial of proteasome inhibitor-based desensitization. Am J Transplant. 2015;15(1):101-118.","journal-title":"Am J Transplant"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1745-6215-15-107","article-title":"Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial","volume":"15","author":"Eskandary","year":"2014","unstructured":"26. Eskandary F, Bond G, Schwaiger E, et al. Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial. Trials. 2014;15:107.","journal-title":"Trials"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T17:04:58Z","timestamp":1570899898000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/forms\/ectrxcontentshow.php?doi_id=10.6002\/ect.2017.0154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2017.0154","relation":{},"ISSN":["1304-0855"],"issn-type":[{"value":"1304-0855","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}